Inventor · disambiguated record
Nadine Ottoson
Also filed as: OTTOSON NADINE
3 granted patents·8 pending applications·7 citations·filing 2016–2024
63Inventor score
Top patents by PatentIndex Score
11 records- 0186US10111901B2Beta-glucan in combination with anti-cancer agents affecting the tumor microenvironmentBIOTHERA INC·Filed 2016·Granted Oct 30, 2018·4 cites·19 claims
- 0284US10111900B2β-glucan methods and compositions that affect the tumor microenvironmentBIOTHERA INC·Filed 2016·Granted Oct 30, 2018·3 cites·20 claims
- 0381US2025114392A1Beta-glucan in combination with anti-cancer agents affecting the tumor micrenvironmentHIBERCELL INC·Filed 2024·Application pending·0 cites
- 0480US2024350528A1Beta-glucan in combination with anti-cancer agents affecting the tumor microenvironmentHIBERCELL INC·Filed 2023·Application pending·0 cites
- 0579US2025114391A1Beta-glucan methods and compositions that affect the tumor microenvironmentHIBERCELL INC·Filed 2024·Application pending·0 cites
- 0668US2022047620A1Beta-glucan in combination with anti-cancer agents affecting the tumor microenvironmentHIBERCELL INC·Filed 2021·Application pending·0 cites
- 0767US2024019444A1Beta glucan immunopharmacodynamicsHIBERCELL INC·Filed 2023·Application pending·0 cites
- 0867US2021283169A1Beta-glucan methods and compositions that affect the tumor microenvironmentHIBERCELL INC·Filed 2021·Application pending·0 cites
- 0963US2019060350A1Beta-glucan methods and compositions that affect the tumor microenvironmentBIOTHERA INC·Filed 2018·Application pending·0 cites
- 1062US2019060351A1Beta-glucan in combination with anti-cancer agents affecting the tumor microenvironmentBIOTHERA INC·Filed 2018·Application pending·0 cites
- 1152US11815435B2Beta glucan immunopharmacodynamicsHIBERCELL INC·Filed 2018·Granted Nov 14, 2023·0 cites·7 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →